PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 27 filers reported holding PROQR THRAPEUTICS N V in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,057 | +72.2% | 10,044 | +114.6% | 0.00% | – |
| Q2 2023 | $7,583 | -1.1% | 4,681 | +30.0% | 0.00% | – |
| Q1 2023 | $7,668 | -29.6% | 3,600 | +22.3% | 0.00% | – |
| Q4 2022 | $10,893 | +172.3% | 2,944 | -42.3% | 0.00% | – |
| Q3 2022 | $4,000 | -99.4% | 5,098 | -94.0% | 0.00% | – |
| Q4 2021 | $675,000 | -14.2% | 84,327 | -10.4% | 0.00% | – |
| Q3 2021 | $787,000 | +88.3% | 94,116 | +51.8% | 0.00% | – |
| Q2 2021 | $418,000 | -30.2% | 62,013 | -31.6% | 0.00% | – |
| Q1 2021 | $599,000 | -69.8% | 90,615 | -80.8% | 0.00% | -100.0% |
| Q4 2020 | $1,983,000 | -13.4% | 472,103 | -1.3% | 0.00% | 0.0% |
| Q3 2020 | $2,291,000 | -21.9% | 478,325 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $2,932,000 | +10.6% | 482,266 | -0.1% | 0.00% | 0.0% |
| Q1 2020 | $2,650,000 | -47.3% | 482,609 | -5.0% | 0.00% | -50.0% |
| Q4 2019 | $5,033,000 | +93.4% | 507,886 | +12.4% | 0.00% | +100.0% |
| Q3 2019 | $2,602,000 | -38.7% | 451,693 | -3.2% | 0.00% | -50.0% |
| Q2 2019 | $4,248,000 | -90.6% | 466,785 | -83.6% | 0.00% | -90.0% |
| Q4 2018 | $45,043,000 | +1125975.0% | 2,854,433 | +1262923.5% | 0.02% | – |
| Q3 2018 | $4,000 | -55.6% | 226 | -92.2% | 0.00% | – |
| Q1 2018 | $9,000 | +50.0% | 2,897 | +53.0% | 0.00% | – |
| Q4 2017 | $6,000 | -50.0% | 1,894 | -21.5% | 0.00% | – |
| Q3 2017 | $12,000 | +33.3% | 2,412 | +36.6% | 0.00% | – |
| Q2 2017 | $9,000 | +50.0% | 1,766 | +37.3% | 0.00% | – |
| Q4 2016 | $6,000 | -53.8% | 1,286 | -51.0% | 0.00% | – |
| Q2 2016 | $13,000 | +62.5% | 2,627 | +174.5% | 0.00% | – |
| Q4 2015 | $8,000 | -55.6% | 957 | -20.4% | 0.00% | – |
| Q3 2015 | $18,000 | +260.0% | 1,203 | +301.0% | 0.00% | – |
| Q2 2015 | $5,000 | -58.3% | 300 | -43.1% | 0.00% | – |
| Q1 2015 | $12,000 | +20.0% | 527 | +19.2% | 0.00% | – |
| Q4 2014 | $10,000 | – | 442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |